bupropion hydrochloride

FDA Drug Profile — Bupropion Hydrochloride (XL), Bupropion Hydrochloride SR, bupropion hydrochloride SR, WELLBUTRIN SR, Bupropion Hydrochloride XL

bupropion hydrochloride is listed in the FDA National Drug Code directory with 172 NDC codes, marketed under brand names including Bupropion Hydrochloride (XL), Bupropion Hydrochloride SR, bupropion hydrochloride SR. Available dosage forms: tablet, extended release, tablet, film coated, extended release, tablet, film coated.

Drug details

Generic Name
bupropion hydrochloride
Brand Names
Bupropion Hydrochloride (XL), Bupropion Hydrochloride SR, bupropion hydrochloride SR, WELLBUTRIN SR, Bupropion Hydrochloride XL, bupropion hydrochloride, BuPROPion Hydrochloride, WELLBUTRIN XL, BUPROPION HYDROCHLORIDE, bupropion
Application Number
ANDA210081
Sponsor
A-S Medication Solutions
NDC Codes
172
Dosage Forms
TABLET, EXTENDED RELEASE, TABLET, FILM COATED, EXTENDED RELEASE, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
BUPROPION HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of bupropion hydrochloride tablets in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies ( 14 )]. Bupropion hydrochloride tablets are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.